A randomised controlled trial of physiotherapy and exercise interventions for ambulatory people with multiple sclerosis (MS)

Completed (inferred)Not a drug-phase studyMS (type not specified)ISRCTN77610415

What it found

Paper found, not read

A paper reports the results; we have not read it yet. See Papers below.

What it measured

Main measures

  • Multiple Sclerosis Impact Scale 29, v2 All primary and secondary outcomes will be assessed at the following timepoins: Week 1, (before intervention), week 12 (after intervention/control period) and week 24 (follow-up)

Other measures (1)

  • 1. Muscle strength using hand held dynamometry 2. Modified Ashworth Scale 3. Physiological Cost Index 4. Six-minute walking test 5. Berg Balance Scale 6. Modified Fatigue Impact Scale All primary and secondary outcomes will be assessed at the following timepoins: Week 1, (before intervention), week 12 (after intervention/control period) and week 24 (follow-up)

    FatigueWalking and mobilityPhysical functionSpasticity

Who could take part

MS (type not specified) · 18 and over

Show the full criteria

Inclusion criteria

Inclusion: 1. Both males and females, aged >=18 2. Diagnosis of MS confirmed by their consultant physician or neurologist 3. Resident in the republic of Ireland Exclusion: 1. Currently experiencing an exacerbation of symptoms due to relapse 2. Patients who have had steroid treatment within 3 months of the baseline measurement 3. Pregnant at time of referral 4. Under 18 years of age

Exclusion criteria

Not separately supplied in the registry.

As registered. Criteria can change, so ask the trial team or your neurologist.

About this trial

In the sponsor's words

Not provided at time of registration

Papers

Loading reviews and guidelines…

History

    1. Started

      Apr 2008

    2. Finished

      Oct 2009

    Assembled by software from public sources.